ArticlePloS one2026
Evaluation of anemia in non-enhanced and contrast-enhanced dual-energy CT using electron density imaging.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electron density (ED) imaging derived from dual-energy CT (DECT) quantifies tissue composition and may reflect changes in red blood cell (RBC) mass associated with anemia. This study aimed to evaluate the utility of ED from DECT in assessing anemia severity using both non-enhanced CT (NECT) and contrast-enhanced CT (CECT), and to investigate its correlation with hemoglobin (Hb), hematocrit (Hct), and RBC count. In this retrospective study, 2,558 patients who underwent NECT and 2,545 who underwent CECT using a dual-layer spectral detector CT (Philips IQon) were included. Mean ED and mean CT attenuation (HU) were measured at five cardiac blood pool sites. Spearman's rank correlation analysis was performed between CT measurements and hematologic parameters. Partial correlation analysis adjusting for age and sex and non-parametric bootstrap internal validation were also conducted. Receiver operating characteristic (ROC) curve analysis was performed to determine diagnostic cutoff values for anemia detection. Mean ED significantly decreased with increasing anemia severity in both NECT and CECT cohorts (all p < 0.001). With NECT, mean ED showed positive correlations with Hb, Hct, and RBC count (rs = 0.726-0.770), with AUCs of 0.825-0.956 for anemia detection. With CECT, mean ED retained positive correlations with hematologic parameters (rs = 0.447-0.583), with AUCs of 0.727-0.895, while mean HU showed no meaningful correlation. After adjustment for age and sex, partial correlation coefficients remained substantial (NECT: rs = 0.694; CECT: rs = 0.509 for Hb), and bootstrap internal validation confirmed negligible overfitting bias. ED derived from DECT demonstrated diagnostic utility for anemia detection on NECT, unlike conventional HU, retained clinically relevant associations with hematologic parameters on CECT. ED-based anemia detection on CECT is best conceptualized as opportunistic detection, particularly for severe anemia, supplementary to laboratory testing. These findings require external validation across diverse DECT platforms before broader clinical implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.